WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,791 Cr | ₹3,435 Cr | ₹3,207 Cr | ₹3,121 Cr | ₹3,497 Cr |
What is the latest Total Current Liabilities ratio of WOCKHARDT ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,791 Cr |
Mar2023 | ₹3,435 Cr |
Mar2022 | ₹3,207 Cr |
Mar2021 | ₹3,121 Cr |
Mar2020 | ₹3,497 Cr |
How is Total Current Liabilities of WOCKHARDT Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,791 Cr | -18.75 | |
Mar2023 | ₹3,435 Cr | 7.11 | |
Mar2022 | ₹3,207 Cr | 2.76 | |
Mar2021 | ₹3,121 Cr | -10.76 | |
Mar2020 | ₹3,497 Cr | - |
Compare Total Current Liabilities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹16,374.7 Cr | 0.3% | 6% | 396.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,336.0 Cr | -1.9% | -0.6% | 64.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,351.0 Cr | -2.5% | 7.1% | 63.9% | Stock Analytics | |
CIPLA | ₹120,235.0 Cr | -2.2% | -9.4% | 26.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,706.0 Cr | -2.7% | -2.7% | 18.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,637.3 Cr | -1.5% | -6.9% | 76.2% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 0.3% |
6% |
396.2% |
SENSEX | -2.2% |
-6.5% |
21.4% |
You may also like the below Video Courses